{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:48:00Z","timestamp":1794023280555,"version":"4.8.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017577","name":"CTI Biopharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017577","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.humpath.2025.105791","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:58:22Z","timestamp":1746777502000},"page":"105791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Chimeric antigen receptor (CAR) T-cell therapy-related gastrointestinal toxicity: Histologic features and morphologic mimics"],"prefix":"10.1016","volume":"158","author":[{"given":"Saman S.","family":"Karimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatianna C.","family":"Larman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysandra","family":"Voltaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-3304","authenticated-orcid":false,"given":"Jacqueline E.","family":"Birkness-Gartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105791_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jtct.2023.07.002","article-title":"Updated indications for immune effector cell therapy: 2023 guidelines from the American Society for Transplantation and Cellular Therapy","volume":"29","author":"Kanate","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.humpath.2025.105791_bib2","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2024e13640","article-title":"CAR-T therapy for gastrointestinal cancers: current status, challenges, and future directions","volume":"57","author":"Li","year":"2024","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.humpath.2025.105791_bib3","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41591-024-03037-z","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results","volume":"30","author":"Qi","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2025.105791_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007927","article-title":"Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells","volume":"12","author":"Botta","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2025.105791_bib5","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/bloodadvances.2020002509","article-title":"Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies","volume":"4","author":"Jain","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.105791_bib6","article-title":"The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.humpath.2025.105791_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13046-021-02148-6","article-title":"Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies","volume":"40","author":"Xiao","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105791_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/14712598.2020.1729735","article-title":"Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy","volume":"20","author":"Chou","year":"2020","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.humpath.2025.105791_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/COC.0000000000000596","article-title":"Gastrointestinal adverse events observed after chimeric antigen receptor T-cell therapy","volume":"42","author":"Abu-Sbeih","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105791_bib10","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/ibd\/izaa320","article-title":"Colitis after CAR T-cell therapy for refractory large B-cell lymphoma responds to anti-integrin therapy","volume":"27","author":"Hashim","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.humpath.2025.105791_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1149450","article-title":"Case report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma","volume":"13","author":"Zundler","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2025.105791_bib12","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.14309\/01.ajg.0001082860.27983.7d","article-title":"S82 CAR T-cell therapy associated with onset of inflammatory bowel disease requiring long-term advanced therapy for control of chronic ileocolitis","volume":"119","author":"Wilson","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2025.105791_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41417-024-00752-0","article-title":"Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: a real-world study","volume":"31","author":"Song","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.humpath.2025.105791_bib14","article-title":"S2743 CAR T-cell therapy-induced pseudomembranous colitis mimicking C. difficile infection","volume":"119","author":"Bashir","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2025.105791_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41408-024-01167-8","article-title":"Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma","volume":"14","author":"Fortuna","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.humpath.2025.105791_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bmt.2009.157","article-title":"A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT","volume":"45","author":"Goddard","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2025.105791_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14740\/gr925w","article-title":"Autologous graft-versus-host disease of the gastrointestinal tract in patients with multiple myeloma and hematopoietic stem cell transplantation","volume":"11","author":"Hammami","year":"2018","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.humpath.2025.105791_bib18","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1093\/ibd\/izab036","article-title":"Onset of suspected ulcerative colitis after treatment with tocilizumab in patient with celiac disease and juvenile idiopathic arthritis","volume":"27","author":"Borghini","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.humpath.2025.105791_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991092","article-title":"Ciltacabtagene autoleucel: the second anti-BCMA CAR T-cell therapeutic armamentarium of relapsed or refractory multiple myeloma","volume":"13","author":"Chekol Abebe","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2025.105791_bib20","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia","volume":"20","author":"Washington","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105791_bib21","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105791_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/cancers15041003","article-title":"Systematic review on CAR-T cell clinical trials up to 2022: academic center input","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2025.105791_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241309825","article-title":"Severe refractory colitis after intraperitoneal infusion of CEA-directed CAR T cells in patients with colorectal cancer","volume":"16","author":"Ye","year":"2024","journal-title":"Ther Adv Med Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T03:09:15Z","timestamp":1762225755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":23,"alternative-id":["S0046817725000784"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105791","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric antigen receptor (CAR) T-cell therapy-related gastrointestinal toxicity: Histologic features and morphologic mimics","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105791"}}